Skip to main content
SpringerLink
Log in
Book cover

Management of Obstructive Sleep Apnea pp 57–66Cite as

Diagnostic Considerations in Metabolic Disease Associated with Obstructive Sleep Apnea

  • Chapter
  • First Online:

  • 1271 Accesses

Abstract

Patients with sleep apnea suffer a high rate of concurrent metabolic disease that includes obesity, hypertension, diabetes mellitus, and fatty liver disease. These metabolic diseases can increase the risk for complications of obstructive sleep apnea that include cardiovascular events and kidney and liver failure. Metabolic disease adds risk to surgical treatment of obstructive sleep apnea through increase in incidence of not only cardiovascular events, but also perioperative hemorrhage, infection, and slow wound healing. Therefore, recognition and treatment of concomitant metabolic disease will decrease risk of adverse outcomes associated with treatment of obstructive sleep apnea. In this chapter, we review recent diagnostic criteria of metabolic disease related to obstructive sleep apnea, and provide tips for diagnosis and treatment with special attention to reduction of perioperative risks.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   49.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   69.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. St-Onge MP, Shechter A. Sleep disturbances, body fat distribution, food intake and/or energy expenditure: pathophysiological aspects. Horm Mol Biol Clin Investig. 2014;17(1):29–37. https://doi.org/10.1515/hmbci-2013-0066.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Depner CM, Stothard ER, Wright KP Jr. Metabolic consequences of sleep and circadian disorders. Curr Diab Rep. 2014;14(7):507. https://doi.org/10.1007/s11892-014-0507-z.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Liu A, Kushida CA, Reaven GM. Habitual shortened sleep and insulin resistance: an independent relationship in obese individuals. Metabolism. 2013;62(11):1553–6. https://doi.org/10.1016/j.metabol.2013.06.003.

    Article  CAS  PubMed  Google Scholar 

  4. Auclair A, Biertho L, Marceau S, Hould FS, Biron S, Lebel S, Julien F, Lescelleur O, Lacasse Y, Piche ME, Cianflone K, Parlee SD, Goralski K, Martin J, Bastien M, St-Pierre DH, Poirier P. Bariatric surgery-induced resolution of hypertension and obstructive sleep apnea: impact of modulation of body fat, ectopic fat, autonomic nervous activity, inflammatory and adipokine profiles. Obes Surg. 2017; https://doi.org/10.1007/s11695-017-2737-z.

  5. Rasheid S, Banasiak M, Gallagher SF, Lipska A, Kaba S, Ventimiglia D, Anderson WM, Murr MM. Gastric bypass is an effective treatment for obstructive sleep apnea in patients with clinically significant obesity. Obes Surg. 2003;13(1):58–61.

    Article  PubMed  Google Scholar 

  6. Foster GD, Borradaile KE, Sanders MH, Millman R, Zammit G, Newman AB, Wadden TA, Kelley D, Wing RR, Pi-Sunyer FX, Reboussin D, Kuna ST, Sleep ARGLARG. A randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes: the Sleep AHEAD study. Arch Intern Med. 2009;169(17):1619–26. https://doi.org/10.1001/archinternmed.2009.266.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Trenell MI, Ward JA, Yee BJ, Phillips CL, Kemp GJ, Grunstein RR, Thompson CH. Influence of constant positive airway pressure therapy on lipid storage, muscle metabolism and insulin action in obese patients with severe obstructive sleep apnoea syndrome. Diabetes Obes Metab. 2007;9(5):679–87. https://doi.org/10.1111/j.1463-1326.2006.00649.x.

    Article  CAS  PubMed  Google Scholar 

  8. Chin K, Shimizu K, Nakamura T, Narai N, Masuzaki H, Ogawa Y, Mishima M, Nakamura T, Nakao K, Ohi M. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation. 1999;100(7):706–12.

    Article  CAS  PubMed  Google Scholar 

  9. Bourey RE, Bourey JR, Habbal N, Balaa A. Early gain in body mass with continuous positive airway pressure therapy for obstructive sleep apnea (Anfängliche Gewichtszunahme bei kontinuierlicher Positivdruck-Therapie wegen obstruktiver Schlafapnoe. Anfängliche Gewichtszunahme bei CPAP-Therapie). Somnologie. 2010;14(3):207–12. https://doi.org/10.1007/s11818-010-0483-8.

    Article  Google Scholar 

  10. American Medical Association (2013) H440.842 Recognition of Obesity as a Disease. Available at: https://www.amaassn.org/ssl3/ecomm/PolicyFinderForm.pl?site=www.ama-assn.org&uri=/resources/html/PolicyFinder/policyfiles/HnE/H-440.842.HTM.

  11. Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, Nadolsky K, Pessah-Pollack R, Plodkowski R, Reviewers of the AACEOCPG. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract. 2016;22(Suppl 3):1–203. https://doi.org/10.4158/EP161365.GL.

    Article  PubMed  Google Scholar 

  12. Tilkian AG, Guilleminault C, Schroeder JS, Lehrman KL, Simmons FB, Dement WC. Hemodynamics in sleep-induced apnea. Studies during wakefulness and sleep. Ann Intern Med. 1976;85(6):714–9.

    Article  CAS  PubMed  Google Scholar 

  13. Coccagna G, Mantovani M, Brignani F, Parchi C, Lugaresi E. Continuous recording of the pulmonary and systemic arterial pressure during sleep in syndromes of hypersomnia with periodic breathing. Bull Physiopathol Respir (Nancy). 1972;8(5):1159–72.

    CAS  Google Scholar 

  14. Carlson JT, Hedner JA, Ejnell H, Peterson LE. High prevalence of hypertension in sleep apnea patients independent of obesity. Am J Respir Crit Care Med. 1994;150(1):72–7. https://doi.org/10.1164/ajrccm.150.1.8025776.

    Article  CAS  PubMed  Google Scholar 

  15. Millman RP, Redline S, Carlisle CC, Assaf AR, Levinson PD. Daytime hypertension in obstructive sleep apnea. Prevalence and contributing risk factors. Chest. 1991;99(4):861–6.

    Article  CAS  PubMed  Google Scholar 

  16. Levinson PD, Millman RP. Causes and consequences of blood pressure alterations in obstructive sleep apnea. Arch Intern Med. 1991;151(3):455–62.

    Article  CAS  PubMed  Google Scholar 

  17. Min HJ, Cho YJ, Kim CH, Kim DH, Kim HY, Choi JI, Lee JG, Park S, Cho HJ. Clinical features of obstructive sleep apnea that determine its high prevalence in resistant hypertension. Yonsei Med J. 2015;56(5):1258–65. https://doi.org/10.3349/ymj.2015.56.5.1258.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Muxfeldt ES, Margallo VS, Guimaraes GM, Salles GF. Prevalence and associated factors of obstructive sleep apnea in patients with resistant hypertension. Am J Hypertens. 2014;27(8):1069–78. https://doi.org/10.1093/ajh/hpu023.

    Article  CAS  PubMed  Google Scholar 

  19. Whelton PK, Carey RM, Aronow WS, Casey DE, Jr., Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC, Jr., Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA, Sr., Williamson JD, Wright JT, Jr. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2017. https://doi.org/10.1161/HYP.0000000000000065.

  20. Kent BD, Grote L, Ryan S, Pepin JL, Bonsignore MR, Tkacova R, Saaresranta T, Verbraecken J, Levy P, Hedner J, McNicholas WT. Diabetes mellitus prevalence and control in sleep-disordered breathing: the European Sleep Apnea Cohort (ESADA) study. Chest. 2014;146(4):982–90. https://doi.org/10.1378/chest.13-2403.

    Article  PubMed  Google Scholar 

  21. Mahmood K, Akhter N, Eldeirawi K, Onal E, Christman JW, Carley DW, Herdegen JJ. Prevalence of type 2 diabetes in patients with obstructive sleep apnea in a multi-ethnic sample. J Clin Sleep Med. 2009;5(3):215–21.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Einhorn D, Stewart DA, Erman MK, Gordon N, Philis-Tsimikas A, Casal E. Prevalence of sleep apnea in a population of adults with type 2 diabetes mellitus. Endocr Pract. 2007;13(4):355–62. https://doi.org/10.4158/EP.13.4.355.

    Article  PubMed  Google Scholar 

  23. Foster GD, Sanders MH, Millman R, Zammit G, Borradaile KE, Newman AB, Wadden TA, Kelley D, Wing RR, Sunyer FX, Darcey V, Kuna ST, Sleep ARG. Obstructive sleep apnea among obese patients with type 2 diabetes. Diabetes Care. 2009;32(6):1017–9. https://doi.org/10.2337/dc08-1776.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Amin A, Ali A, Altaf QA, Piya MK, Barnett AH, Raymond NT, Tahrani AA. Prevalence and associations of obstructive sleep apnea in South Asians and White Europeans with type 2 diabetes: a cross-sectional study. J Clin Sleep Med. 2017;13(4):583–9. https://doi.org/10.5664/jcsm.6548.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Donovan LM, Rueschman M, Weng J, Basu N, Dudley KA, Bakker JP, Wang R, Bertisch SM, Patel SR. The effectiveness of an obstructive sleep apnea screening and treatment program in patients with type 2 diabetes. Diabetes Res Clin Pract. 2017;134:145–52. https://doi.org/10.1016/j.diabres.2017.10.013.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Ziegler AG, Pflueger M, Winkler C, Achenbach P, Akolkar B, Krischer JP, Bonifacio E. Accelerated progression from islet autoimmunity to diabetes is causing the escalating incidence of type 1 diabetes in young children. J Autoimmun. 2011;37(1):3–7. https://doi.org/10.1016/j.jaut.2011.02.004.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Verbeeten KC, Elks CE, Daneman D, Ong KK. Association between childhood obesity and subsequent Type 1 diabetes: a systematic review and meta-analysis. Diabet Med. 2011;28(1):10–8. https://doi.org/10.1111/j.1464-5491.2010.03160.x.

    Article  CAS  PubMed  Google Scholar 

  28. American Diabetes Association. Standards of medical care in diabetes – 2017. Diabetes Care. 2017;40(Suppl 1):S1–S135. https://doi.org/10.2337/dc17-S001.

    Article  Google Scholar 

  29. Gallagher EJ, Le Roith D, Bloomgarden Z. Review of hemoglobin A(1c) in the management of diabetes. J Diabetes. 2009;1(1):9–17. https://doi.org/10.1111/j.1753-0407.2009.00009.x.

    Article  CAS  PubMed  Google Scholar 

  30. American Association of Clinical Endocrinologists Board of D, American College of Endocrinologists Board of T. American Association of Clinical Endocrinologists/American College of Endocrinology statement on the use of hemoglobin A1c for the diagnosis of diabetes. Endocr Pract. 2010;16(2):155–6. https://doi.org/10.4158/EP.16.2.155.

    Article  Google Scholar 

  31. Kim WR, et al. (2015) OPTN/SRTR 2015 Annual data report: liver. http://srtr.transplant.hrsa.gov/annual_reports/Default.aspx.

  32. Younossi ZM, Stepanova M, Afendy M, Fang Y, Younossi Y, Mir H, Srishord M. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol. 2011;9(6):524–30. e521; quiz e560. https://doi.org/10.1016/j.cgh.2011.03.020.

    Article  PubMed  Google Scholar 

  33. Benotti P, Wood GC, Argyropoulos G, Pack A, Keenan BT, Gao X, Gerhard G, Still C. The impact of obstructive sleep apnea on nonalcoholic fatty liver disease in patients with severe obesity. Obesity (Silver Spring). 2016;24(4):871–7. https://doi.org/10.1002/oby.21409.

    Article  Google Scholar 

  34. Musso G, Olivetti C, Cassader M, Gambino R. Obstructive sleep apnea-hypopnea syndrome and nonalcoholic fatty liver disease: emerging evidence and mechanisms. Semin Liver Dis. 2012;32(1):49–64. https://doi.org/10.1055/s-0032-1306426.

    Article  CAS  PubMed  Google Scholar 

  35. Aron-Wisnewsky J, Minville C, Tordjman J, Levy P, Bouillot JL, Basdevant A, Bedossa P, Clement K, Pepin JL. Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese. J Hepatol. 2012;56(1):225–33. https://doi.org/10.1016/j.jhep.2011.04.022.

    Article  CAS  PubMed  Google Scholar 

  36. Qi JC, Huang JC, Lin QC, Zhao JM, Lin X, Chen LD, Huang JF, Chen X. Relationship between obstructive sleep apnea and nonalcoholic fatty liver disease in nonobese adults. Sleep Breath. 2016;20(2):529–35. https://doi.org/10.1007/s11325-015-1232-9.

    Article  PubMed  Google Scholar 

  37. Ghosh S, Kaw M, Patel PR, Ledford KJ, Bowman TA, McInerney MF, Erickson SK, Bourey RE, Najjar SM. Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. Hepat Med. 2010;2010(2):69–78. https://doi.org/10.2147/HMER.S8902.

    Article  PubMed  Google Scholar 

  38. Aberg F, Helenius-Hietala J, Puukka P, Farkkila M, Jula A. Interaction between alcohol consumption and metabolic syndrome in predicting severe liver disease in the general population. Hepatology. 2017. https://doi.org/10.1002/hep.29631.

  39. Kotronen A, Peltonen M, Hakkarainen A, Sevastianova K, Bergholm R, Johansson LM, Lundbom N, Rissanen A, Ridderstrale M, Groop L, Orho-Melander M, Yki-Jarvinen H. Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. Gastroenterology. 2009;137(3):865–72. https://doi.org/10.1053/j.gastro.2009.06.005.

    Article  CAS  PubMed  Google Scholar 

  40. Alberti KG, Zimmet P, Shaw J, Group IDFETFC. The metabolic syndrome--a new worldwide definition. Lancet. 2005;366(9491):1059–62. https://doi.org/10.1016/S0140-6736(05)67402-8.

    Article  PubMed  Google Scholar 

  41. Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33. https://doi.org/10.1186/1471-230X-6-33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Unal E, Idilman IS, Karcaaltincaba M. Multiparametric or practical quantitative liver MRI: towards millisecond, fat fraction, kilopascal and function era. Expert Rev Gastroenterol Hepatol. 2017;11(2):167–82. https://doi.org/10.1080/17474124.2017.1271710.

    Article  CAS  PubMed  Google Scholar 

  43. Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, M SS, Torriani FJ, Dieterich DT, Thomas DL, Messinger D, Nelson M, Investigators AC. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006;43(6):1317–25. https://doi.org/10.1002/hep.21178.

    Article  CAS  PubMed  Google Scholar 

  44. McPherson S, Stewart SF, Henderson E, Burt AD, Day CP. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. Gut. 2010;59(9):1265–9. https://doi.org/10.1136/gut.2010.216077.

    Article  PubMed  Google Scholar 

  45. Singh S, Muir AJ, Dieterich DT, Falck-Ytter YT. American Gastroenterological Association Institute technical review on the role of elastography in chronic liver diseases. Gastroenterology. 2017;152(6):1544–77. https://doi.org/10.1053/j.gastro.2017.03.016.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Endocrinology, Diabetes, and Metabolism, Saint Louis University, St. Louis, MO, USA

    Raymond E. Bourey

Authors
  1. Raymond E. Bourey
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Raymond E. Bourey .

Editor information

Editors and Affiliations

  1. Orthodontics, Saint Louis University Orthodontics, Saint Louis, MO, USA

    Ki Beom Kim

  2. Orthodontics, Saint Louis University Orthodontics, Saint Louis, MO, USA

    Reza Movahed

  3. Washington University in St. Louis School of Medicine, Saint Louis, MO, USA

    Raman K. Malhotra

  4. Otolaryngology-Head and Neck Surgery, University of Michigan–Ann Arbor, Ann Arbor, MI, USA

    Jeffrey J. Stanley

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Bourey, R.E. (2021). Diagnostic Considerations in Metabolic Disease Associated with Obstructive Sleep Apnea. In: Kim, K.B., Movahed, R., Malhotra, R.K., Stanley, J.J. (eds) Management of Obstructive Sleep Apnea. Springer, Cham. https://doi.org/10.1007/978-3-030-54146-0_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-54146-0_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-54145-3

  • Online ISBN: 978-3-030-54146-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation